American College of Endocrinology Self-Assessment Program

Estimated Time to Complete the 11 sections of ASAP: 76.0 hours
Dates of Original Release: May 2001, April 2005 (Syllabus Format)
Date of Most Recent Review and Update: August 2011
Date of Release: August 23, 2011
Termination Date or Date Credit Expires: August 23, 2014
Medium or Combination of Media Used: Online Manuscripts
Hardware Requirements Needed to Participate: Any Web Browser with Javascript and cookies enabled.
Pricing: AACE Members $225
AACE Members - Fellow-in-Training $125
AACE Member - Retired $150.00
Residents $75
Medical Students $25
Non-AACE Members $325
This activity has been approved for AMA PRA Category 1 Credit(s)™.
Credit available for the American Board of Internal Medicines (ABIM) Maintenance of Certification (MOC) program.

For questions regarding this CME activity, please contact:
AACE c/o Emily Hines
Phone: 904-353-7878, ext. 171
Email: Emily Hines

What is ASAP?

American College of Endocrinology Self-Assessment Program provides a core curriculum with updated information on the evaluation, diagnosis, treatment, and management of endocrine disease. American College of Endocrinology Self-Assessment Program fulfills the cognitive needs of the endocrinologist to be effective and competent in delivering optimal endocrine care and assists endocrinologists in preparation and maintenance of their subspecialty certification.


What Areas Will ASAP Cover?

  • Disorders of the Adrenal Gland
  • Diabetes Mellitus
  • Hypertension
  • Hypoglycemic Disorders
  • Disorders of the Pituitary Gland
  • Reproductive Endocrinology Disorders
  • Disorders of the Thyroid Gland
  • Serum Lipid Disorders
  • Nutrition Disorders and Management
  • Parathyroid and Bone Mineral Disorders
  • Pediatric Endocrinology Disorders

How Can You Complete the 2011 ASAP Program?

  • Create an ASAP account via the AACE Website.

  • Review the online study materials and complete the online post tests for the 11 sections related to the field of endocrinology.

Will You Get CME Credits for Completing ASAP?

  • Yes! This activity has been approved for a maximum of 76.0 AMA PRA Category 1 Credit(s)™.
  • Score 75% or higher on the post activity assessments and complete the online evaluation form and your CME certificate will automatically display for you to print for your records.

Will I Receive ABIM MOC Credit for Completing ASAP?

  • Yes! The 2011 edition of ASAP has been accepted as part of the Maintenance of Certification (MOC) program of the American Board of Internal Medicine (ABIM).
  • ASAP sections have been grouped to form ABIM modules. If you have successfully completed the ASAP post activity assessments within the ABIM module, you can submit for MOC credit via a direct data transmission feature incorporated into ASAP.

How Much Does ASAP Cost?

  • AACE Member: $225.00
  • AACE Member - Fellow-in-Training: $125
  • AACE Member - Residents: $75
  • AACE Member - Medical Students: $25
  • AACE Member - Retired (Retired Domestic, Retired International, Senior Domestic, Emeritus Domestic, & Emeritus International): $150.00
  • Non-Member: $325.00

How to receive AMA PRA Category 1 Credit(s)™:

  • Register online for ASAP.
  • Read the all information included on ASAP page including information found on the ‘CME’ tab.
  • Read and study a section in its entirety.
  • Complete the post activity assessment and get a passing mark of 75% or higher.
    • NOTE: Participants will be given three (3) attempts to pass the post activity assessment per section.
    • NOTE: Participants will be blocked from further attempts after three (3) failed self assessment attempts for a particular section.
    • NOTE: Participants will have 30 calendar days to complete the post activity assessment, per attempt, up to three (3) attempts.
    • NOTE: Only those who pass the post activity assessment with a score of 75% or higher will receive credit.
  • Following successful completion of the post activity assessment, you must complete the activity evaluation in order to receive the CME certificate for a section.
  • Following completion of the activity evaluation, participants will be able to print his/her CME certificates.
  • Participants will have the option to print the CME certificate every time a section has been successfully completed; or they may print the CME certificate at a later time.
  • This activity expires on date. In order to receive credit, participants must complete the activity by the expiration date. Following this date, the activity will no longer be available for credit.
  • Please note that CME credit was designated for each section of ASAP. The following are the 2011 ASAP sections with their respective credit hours:
2011 ASAP Sections Credit Hours
Disorders of the Adrenal Gland 8.0
Diabetes Mellitus 12.0
Hypertension 5.0
Hypoglycemic Disorders 4.0
Serum Lipid Disorders 6.0
Nutrition Disorders and Management 5.0
Parathyroid and Bone Mineral Disorders 7.0
Pediatric Endocrinology Disorders 6.0
Disorders of the Pituitary Gland 8.0
Reproductive Endocrinology Disorders 7.0
Disorders of the Thyroid Gland 8.0

How to receive American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) credit:

  • Register online for ASAP.
  • ASAP sections have been grouped to form modules that are available for MOC credit. These modules are as follows:
ASAP 2011 ABIM Modules Number of Post Test Questions MOC Credit
Module 1: Disorders of the Adrenal Gland & Hypertension 62 20
Module 2: Diabetes Mellitus & Hypoglycemic Disorders 77 30
Module 3: Serum Lipid Disorders 37 10
Module 4: Nutrition Disorders & Management 30 10
Module 5: Disorders of the Pituitary Gland 46 10
Module 6: Disorders of the Thyroid Gland 37 10
Module 7: Parathyroid & Bone Mineral Disorders 34 10
Module 8: Reproductive Endocrinology Disorders 31 10
  • In order to receive MOC credit for a module, participants must have successfully completed the related post activity assessments for AMA PRA Category 1 Credit(s)™.
  • Example: In order to receive ABIM MOC credit for Module 1: Disorders of the Adrenal Gland & Hypertension, you must first successfully complete the post activity assessments for the Disorders of the Adrenal Gland and Hypertension sections of ASAP.
  • Once you have successfully completed the post activity assessments associated with a particular module, you can then submit for ABIM MOC credit via the direct data transmission feature found within ASAP.
  • Each module contains instructions for submission.
  • ASAP Editor-in-Chief
  • Diabetes Mellitus
  • Disorders of the Adrenal Gland
  • Disorders of the Pituitary Gland
  • Disorders of the Thyroid Gland
  • Hypertension
  • Hypoglycemic Disorders
  • Nutrition Disorders and Management
  • Parathyroid and Bone Mineral Disorders
  • Pediatric Endocrinology Disorders
  • Reproductive Endocrinology Disorders
  • Serum Lipid Disorders

Pasquale J. Palumbo, MD, MACP, MACE
Editor-in-Chief
ACE Self-Assessment Program
Professor of Medicine
Mayo Clinic College of Medicine
Mayo Clinic Arizona
Scottsdale, AZ


Diabetes Mellitus


Section Editor


Susan S. Braithwaite, MD, FACP, FACE
Visiting Clinical Professor of Medicine,
University of Illinois-Chicago
Staff Physician
Saint Francis Hospital
Evanston, IL


Section Authors


Salomon Banarer, MD
Staff Physician
Dallas Diabetes and Endocrine Center
Dallas, TX


Matthew J. Brady, PhD
Associate Professor of Medicine, Section of Endocrinology
The University of Chicago
Chicago, IL


Carolina M. Casellini, MD
Medical Doctor for the Specialty of Rheumatology
Internal Medicine Department – Rheumatology Section
Centro de Educación Médica e Investigaciones Clínicas (CEMIC).
Buenos Aires, Argentina


Ronald N. Cohen, MD
Associate Professor of Medicine, Section of Endocrinology
The University of Chicago
Chicago, IL


Thomas W. Gardner, MD, MS
Vice-Chair for Research, Department of Ophthalmology
Penn State College of Medicine
Hummelstown, PA


Lois G. Jovanovic, MD, MACE
CEO & Chief Scientific Officer
Sansum Diabetes Research Institute
Adjunct Professor of Chemical Engineering & Biomolecular
Science and Engineering
University of California, Santa Barbara
Clinical Professor of Medicine
University of Southern California, Keck School of Medicine
Los Angeles, CA


Abbas E. Kitabchi, PhD, MD, FACP, FACE
Professor of Medicine and Molecular Sciences
Maston K. Callison Professor
The University of Tennessee Health Science Center
Memphis, TN


Bethany J. Klopfenstein, MD
Assistant Professor
Division of Endocrinology, Diabetes and Clinical Nutrition
Oregon Health & Science University
Portland, OR


Dan Lender, MD, FACP
Director of the Diabetes Clinic for Meuhedet
Hadassah Hebrew University Hospital
Diabetes Unit, Division of Internal Medicine
Jerusalem, Israel


Michelle F. Magee, MD, MBBCh, BAO
MedStar Diabetes Institute
Associate Professor of Medicine
Georgetown University School of Medicine
Washington, DC


Anthony L. McCall, MD, PhD, FACP
James M. Moss Professor in Diabetes and Internal Medicine
Director, Clinical Diabetes Services
University of Virginia Health System
Charlottesville, VA


Anson Pham, MD
Researcher
MedStar Diabetes Institute
Washington Hospital Center
Washington, DC


Kristina I. Rother, MD
Staff Clinician, Clinical Endocrinology Branch
The National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Bethesda, MD


Ravi S. J. Singh, MD
Resident, Penn State Hershey Eye Center,
Penn State Hershey Medical Center & College of Medicine,
Hershey, PA


Elizabeth A. Stephens, MD
Affiliate Associate Professor of Medicine
Division of Endocrinology, Diabetes and Clinical Nutrition
Oregon Health and Science University
Endocrine Chief, Medical Education Department
Providence Portland Medical Center
Portland, OR


Kristin V. Tarbell, PhD
Tenure-track Investigator, Diabetes Branch
The National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Bethesda, MD


Aaron I. Vinik, MD, PhD
Professor of Internal Medicine, Pathology and Neurobiology
Director of Research and Neuroendocrine Unit
Eastern Virginia Medical School
The Strelitz Diabetes Center
Norfolk, VA


Sydney A. Westphal, MD
Senior Associate Consultant
Division of Endocrinology, Department of Internal Medicine
Mayo Clinic
Scottsdale, Arizona


Dwain E. Woode, MD
Fellow, Division of Endocrinology
Department of Medicine
The University of Tennessee Health Science Center
Memphis, TN


Disorders of the Adrenal Gland

Section Editors


Amir Hamrahian, MD, FACE
Director, Clinical Research
Endocrine and Metabolism Institute
Cleveland Clinic


Intekhab Ahmed, M.D., FACP, FACE
Associate Professor of Clinical Medicine
Division of Endocrinology, Diabetes and Metabolic Diseases
Jefferson Medical College
Philadelphia, PA


Section Authors


David C. Aron, MD, MS
Professor of Medicine and Epidemiology and Biostatistics
Case Western Reserve University School of Medicine
Associate Chief of Staff/Education, Louis Stokes Cleveland VA Medical Center
Cleveland, OH


Robert J. Anderson, MD, FACP, FACE
Professor of Medicine and Biomedical Sciences
Creighton University School of Medicine
Chief, Section of Endocrinology, Diabetes and Metabolism
VA Nebraska-Western Iowa Health Care System
Omaha, NE


Emmanuel L. Bravo, MD
Consultant Staff
Department of Nephrology and Hypertension
Cleveland Clinic
Cleveland, OH


Vicky O. Cheng, MD
Fellow, Endocrinology Diabetes and Metabolism
Cleveland Clinic Foundation Program
Cleveland, OH


Andjela Drincic, MD
Associate Professor of Medicine
Program Director, Endocrinology Fellowship
Creighton University School of Medicine
Omaha, NE


Mouhammed Amir Habra, M.D., F.A.C.P., F.A.C.E
Assistant Professor
Department of Endocrine Neoplasia and Hormonal Disorders,
Division of Internal Medicine
The University of Texas, M. D. Anderson Cancer Center
Houston, TX


Adriana G. Ioachimescu, MD, PhD
Attending Endocrinologist, Emory University Hospital
Co-Director, Emory Neuroendocrine Pituitary Center
Assistant Professor, Department of Medicine and Neurological Surgery
Emory University School of Medicine
Atlanta, GA


Melissa Li-Ng, MD
Associate Staff Physician
Endocrinology & Metabolism Institute
Cleveland Clinic Foundation
Cleveland, OH


Antoine Makdissi, MD
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
State University of New York at Buffalo
Buffalo, NY


Mario Skugor, MD, FACE
Associate professor of Medicine at Cleveland Clinic Learner College of Medicine of Case Western Reserve University
Associate director of Endocrinology, Diabetes and Metabolism Fellowship
at Cleveland Clinic
Cleveland, OH


Disorders of the Pituitary Gland

Section Editor


Romesh Khardori, MD, MB, PhD
Professor, Department of Endocrinology
Chief--Division of Endocrinology, Metabolism & Molecular Medicine
Southern Illinois University School of Medicine
Springfield, IL


Section Authors


Beverly M.K. Biller, MD
Professor of Medicine
Harvard Medical School
Neuroendocrine Unit
Massachusetts General Hospital
Boston, MA


Rhoda H. Cobin, MD, MACE
Clinical Professor of Medicine
The Mount Sinai School of Medicine
New York, NY


David M. Cook, MD
Professor & Interim Division Chief
Division of Endocrinology
Oregon Health and Science University
Portland, OR


Jose A. Espinosa, MD
Associate Professor and Chair
Division of Neurosurgery
Department of Surgery
Southern Illinois University School of Medicine
Springfield, IL


Shereen Ezzat, MD, FRCPC, FACP
Professor of Medicine and Oncology
Head, Endocrine Oncology Site Group
University Health Network
Toronto, Ontario, Canada


Carmel Fratianni, MD, FACE
Associate Professor
Division of Endocrinology, Metabolism and Molecular Medicine
Department of Internal Medicine
Southern Illinois University School of Medicine
Springfield, IL


Isabelle M. Germano, MD, FACS
Professor of Neurosurgery, Neurology and Oncological Sciences
Mount Sinai School of Medicine
New York, NY


Suzan Gharaibeh, MD
Consultant Endocrinologist
Al Noor Hospital (Khalifa Branch)
Abu Dhabi City, United Arab Emirates


Ketan G. Goswami, MD
Staff Physician
North Atlanta Endocrinology and Diabetes
Lawrenceville, GA


Sheryl Green, MD, MBBCh
Assistant Professor
Department of Radiation Oncology
Mount Sinai Medical Center
New York, NY


Smita Gupta, MD
Assistant Professor
Division of Endocrinology, Metabolism and Molecular Medicine
Southern Illinois University School of Medicine
Springfield, IL


Caroline B. Huang, MD
Clinical Assistant Professor of Medicine,
Georgetown University Medical Center, Washington DC
Partner, The Endocrinology Group PLLC,
Arlington VA


Kalmon D. Post, MD, FACS
Chairman Emeritus and Professor
Department of Neurosurgery
Mount Sinai Medical Center
New York, NY


Joseph G. Verbalis, MD
Professor of Medicine
Chief, Division of Endocrinology and Metabolism
Co-Director, Georgetown-Howard Universities Center for
Clinical and Translational Science,
Georgetown University Medical Center
Washington, DC


Disorders of the Thyroid Gland


Section Editor


M. Regina Castro, MD, FACE
Consultant, Division of Endocrinology, Diabetes,
Metabolism, & Nutrition
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Rochester, MN


Section Authors


Michael Garcia, MD, MACE
Staff Physician
William Beaumont Hospital
Royal Oak, MI


Roberto E. Izquierdo, MD
Professor of Medicine and Pediatrics, Division of Endocrinology
Associate Medical Director, Joslin Diabetes Center
SUNY Upstate Medical University
Syracuse, NY


Stephanie L. Lee, Ph.D., M.D., F.A.C.E.
Director
BMC Thyroid Nodule and Cancer Center
Boston Medical Center
Associate Professor of Medicine
Boston University School of Medicine
Boston, MA


Bryan McIver, MD
Consultant, Division of Endocrinology, Diabetes,
Metabolism, & Nutrition
Department of Internal Medicine
Mayo Clinic
Rochester, MN


Marius N. Stan, MD
Instructor, College of Medicine
Senior Associate Consultant, Division of Endocrinology,
Diabetes, Metabolism, & Nutrition
Mayo Clinic
Rochester, Minnesota


Sydney A. Westphal, MD
Senior Associate Consultant
Division of Endocrinology, Department of Internal Medicine
Mayo Clinic
Scottsdale, Arizona


Hypertension


Section Editor


Joseph J. Torre, MD, FACP, FACE
Clinical Assistant Professor of Medicine
State University of New York
University at Buffalo School of Medicine and Biomedical Sciences
Buffalo, NY


Section Authors


Zachary T. Bloomgarden, MD, FACE
Clinical Professor
Division of Endocrinology
Mount Sinai School of Medicine
New York, New York


James Bonucchi, DO, ECNU
Endocrinologist
Adult Medicine and Endocrine Specialists,
CoxHealth
Springfield, MO


Michael J. Hogan, MD, MBA
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Scottsdale, AZ


Sunder Raj D. Mudaliar, MD, FACE
Clinical Professor of Medicine
University of California, San Diego
Staff Physician
VA San Diego Healthcare System
San Diego, CA


Angelina L. Trujillo, MD, FACE
Adjunct Senior Investigator
Sansum Diabetes Research Institute
Santa Barbara, CA


Hypoglycemic Disorders


Section Editor


Adrian Vella, MD
Professor of Medicine
Department of Endocrinology
Mayo Clinic College of Medicine
Rochester, MN


Section Authors


F. John Service, MD, PhD, FACP, FRCPC, FACE
Emeritus Professor of Medicine
Mayo Clinic College of Medicine
Rochester, MN


Pankaj Shah, MD
Senior Associate Consultant
Division of Endocrinology, Metabolism, Diabetes, & Nutrition
Mayo Clinic
Rochester, MN


Nutrition Disorders and Management


Section Editor


Jeffrey I. Mechanick, MD, FACP, FACE, FACN
Director, Metabolic Support
Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Bone Disease
Mount Sinai School of Medicine
New York, NY


Section Authors


Harold E. Bays, MD, FACP, FACE
Medical Director / President
Louisville Metabolic and Atherosclerosis Research Center Inc.
Louisville KY


Elise M. Brett, MD, FACE
Associate Clinical Professor of Medicine
Division of Endocrinology, Diabetes, and Bone Disease
Mount Sinai School of Medicine
New York, NY


Maria L. Collazo-Clavell, MD, FACE
Associate Professor of Medicine
Consultant, Division of Endocrinology, Metabolism, Diabetes, & Nutrition
Mayo Clinic College of Medicine
Rochester, MN


J. Michael Gonzalez-Campoy, MD, PhD, FACE
Medical Director and Chief Executive Officer
Minnesota Center for Obesity, Metabolism and Endocrinology
Clinical Assistant Professor of Medicine
University of Minnesota
Eagan, MN


Osama Hamdy, MD, PhD, FACE
Medical Director
Joslin Obesity Clinical Program
Joslin Diabetes Center
Assistant Professor of Medicine,
Harvard Medical School
Boston, MA


Karen McCowen, MD, MRCPI, ECNU
Assistant Professor, Harvard Medical School
Harvard Vanguard Medical Associates
Boston, MA


Asha Thomas, MD, FACP, FACE
Assistant Professor of Medicine, Division of Endocrinology, Department of Medicine
Johns Hopkins University School of Medicine
Division Director, Sinai Hospital of Baltimore,
Division of Endocrinology and Metabolism
Baltimore, MD


Michael A. Via, MD
Assistant Professor of Medicine
Director, Nutrition and Metabolic Support
Division of Endocrinology and Metabolism
Beth Israel Medical Center
New York, NY


Daniel Weiss MD, FACP, CDE, PNS, CPI
Director
Your Diabetes Endocrine Nutrition Group, Inc.
Mentor, Ohio


Parathyroid and Bone Mineral Disorders


Section Editor


Bart L. Clarke, MD, FACE
Associate Professor of Medicine
Consultant, Department of Medicine, Division of Endocrinology,
Diabetes, Metabolism, and Nutrition
Mayo Clinic, College of Medicine
Rochester, MN


Section Authors


Pauline M. Camacho, MD, FACE
Associate Professor of Medicine
Division of Endocrinology and Metabolism
Loyola University Medical Center
Director, Loyola University Osteoporosis and Metabolic Bone Disease Center
Maywood, IL


Daniel L. Hurley, MD, FACE
Assistant Professor of Medicine
Consultant, Division of Endocrinology, Diabetes, Metabolism, and Nutrition
Mayo Clinic, College of Medicine
Rochester, MN


Ann E. Kearns, MD, PhD
Assistant Professor of Medicine
Consultant, Division of Endocrinology, Diabetes, Metabolism, and Nutrition
Mayo Clinic, College of Medicine
Rochester, MN


Michael Kleerekoper, MD, FACP, MACE, FACB
Clinical Professor
Wayne State University School of Medicine
Division of Endocrinology
Detroit, MI


Robert A. Wermers, MD
Assistant Professor of Medicine
Consultant, Division of Endocrinology, Diabetes, Metabolism, and Nutrition
Mayo Clinic, College of Medicine
Rochester, MN


Pediatric Endocrinology Disorders


Section Editor


Phyllis W. Speiser, MD, FACE
Professor of Pediatrics
Hofstra-North Shore LIJ School of Medicine
Chief, Division of Pediatric Endocrinology
Steven & Alexandra Cohen Childrens Medical Center of New York
New Hyde Park, NY


Section Authors


Karen Burns, MD
Assistant Professor of Clinical Pediatrics
Director, ATP Cancer Survivor Center
Division of Hematology/Oncology
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH


Ming Chen, MD, PhD
Assistant Professor of Pediatrics
Division of Pediatric Endocrinology
University of Michigan Medical School
Ann Arbor, MI


Sunita Cheruvu, MD
Fellow, New York-Presbyterian Hopital
Weill Cornell Medical Center
Pediatric Endocrinology
New York, NY

Michael J. Haller, MD
Assistant Professor
Department of Pediatrics, Division of Endocrinology
University of Florida
Gainesville, FL


Seema Kumar, MBBS, MD
Assistant Professor
Division of Pediatric Endocrinology
Department of Pediatric and Adolescent Medicine
Mayo Clinic College of Medicine
Rochester, MN


Ian Marshall, MD
Assistant Professor
Division of Pediatric Endocrinology
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Medical School
New Brunswick, NJ


Ram K. Menon, MD
Professor, Departments of Pediatrics and
Molecular and Integrative Physiology Director,
Division of Pediatric Endocrinology
University of Michigan Medical School
Ann Arbor, MI


Nicole Nader, MD
Fellow in Pediatric Endocrinology, Mayo Graduate School of Medicine
Instructor in Pediatrics, Mayo Clinic College of Medicine
Rochester, MN


Henry J. Rohrs, MD
Assistant Professor
Pediatric Endocrinology
University of Florida College of Medicine
Gainesville, FL


Susan R. Rose, MD
Professor of Pediatrics and Endocrinology
Cincinnati Children’s Hospital Medical Center
University of Cincinnati
Cincinnati, OH


Arlan L. Rosenbloom, MD
Adjunct Distinguished Service Professor Emeritus of Pediatrics
Department of Pediatrics
University of Florida College of Medicine
Gainesville, FL


Karen Rubin, MD
Professor & Chief, Pediatric Endocrinology
Associate Clinical Chair, Dept. of Pediatrics
Connecticut Childrens Medical Center
Hartford, CT
University of Connecticut School of Medicine
Farmington, CT


W. Frederick Schwenk, II, MD
Professor of Pediatrics
Chair, Division of Pediatric Endocrinology
Mayo Clinic College of Medicine
Rochester, MN


Janet H. Silverstein, MD
Professor of Pediatrics
Chief, Division of Endocrinology
University of Florida College of Medicine
Gainesville, FL


Inas H. Thomas, MD
Assistant Professor of Pediatrics
Division of Pediatric Endocrinology
University of Michigan Medical School
Ann Arbor, MI


Reproductive Endocrinology Disorders


Section Editor


Batul Valika, MD
Endocrinologist
Endocrinology and Reproductive Medicine
Aurora Medical Group
St. Luke’s and West Allis Memorial Hospital
Milwaukee, WI


Section Authors


Anil Chandel, MD
Endocrinologist
Aurora Medical Group, St. Luke’s Medical Center
Milwaukee, WI


Glenn R. Cunningham, MD
Professor of Medicine
Professor of Molecular and Cellular Biology
Baylor College of Medicine
Medical Director, St. Lukes/Baylor Diabetes Program
St. Lukes Episcopal Hospital
Houston, TX


Walter Futterweit, MD, FACP, FACE
Clinical Professor of Medicine
Division of Endocrinology
Mount Sinai School of Medicine
New York, NY


Neil F. Goodman, MD, FACE
Professor of Medicine
Voluntary Faculty
University of Miami Miller School of Medicine
Miami, FL


Michael J. Heard, MD, FACOG
Reproductive Endocrinologist
The Womens Specialists of Houston
at Texas Childrens Hospital
Clinical Assistant Professor
Baylor College of Medicine
Houston, TX


Luis J. Rodriguez-Rigau, MD, FACE
Clinical Associate Professor
The University of Texas Medical School at Houston
Texas Institute for Reproductive Medicine and Endocrinology
Houston, TX


Keith D. Smith, MD, FACE
Staff Physician
Texas Institute for Reproductive Medicine and Endocrinology
Houston, TX


Randall J. Urban, MD
Edward Randall & Edward Randall, Jr.,
Distinguished Chair in Internal Medicine
Professor and Chair, Department of Internal Medicine
University of Texas Medical Branch
Galveston, TX


Serum Lipid Disorders


Section Editor


Donald Smith, MD, MPH
Associate Professor of Medicine, Community and Preventative Medicine
Director, Lipids and Metabolism
Cardiovascular Institute
Mount Sinai Medical Center
New York, NY


Section Authors


Michael P. Dubé, MD
Professor of Clinical Medicine
University of Southern California Keck School of Medicine
Department of Medicine, Division of Infectious Diseases
Los Angeles County-USC Medical Center
Los Angeles, CA


Paul S. Jellinger, MD, MACE
Professor of Clinical Medicine
University of Miami School of Medicine
Division of Endocrinology, Diabetes and Metabolism
Miami, Florida
The Center for Diabetes and Endocrine Care
Hollywood, FL


Adi E. Mehta, MD
Endocrinologist
Department of Endocrinology, Diabetes and Metabolism
Cleveland Clinic
Cleveland, OH


Terri Montague, MD
Assistant Professor of Medicine
Brown University-Warren Alpert Medical School
Providence, RI


Barbara T. Murphy, MB, BAO, BCh, FRCPI
Professor
Chief, Division of Nephrology
Mount Sinai School of Medicine
New York, NY


Timothy O’Brien, MD, PhD, FRCPI, FRCP(UK), FACP, FACE
Professor and Chair of Medicine
Director of Regenerative Medicine Institute
National University of Ireland
Galway, Ireland


Arti Patel, MD, CNSP
Endocrinologist
RPS Endocrinology
Reading Hospital and Medical Center
Reading, PA


Helena W. Rodbard, MD, FACP, MACE
Medical Director
Endocrine and Metabolic Consultants
Rockville, MD


  • Needs Assessment
  • Learning Objectives
  • Target Audience
  • Learner Bill of Rights
  • Accreditation Statement
  • Disclosure Information
  • Committee Disclosures
  • Section Editor Disclosures
  • Author Disclosures
  • Medical Writer Disclosures

Needs Assessment

The mission of the American Association of Clinical Endocrinologists (AACE) includes improving the care of patients with endocrine disorders through identification and promotion of best clinical practices, through promotion of clinical endocrine research, and through continuing medical education (CME). As part of the commitment of AACE to CME, AACE has established in conjunction with the American College of Endocrinology (ACE) a variety of educational instruments and programs for its membership including the journal, Endocrine Practice, and the ACE Self-Assessment Program (ASAP).

The ASAP was established in 2001 by identification of the 10 areas relative to clinical endocrinology and by identification of panel of experts in theses areas: Disorders of the Adrenal Gland; Diabetes Mellitus; Hypertension; Hypoglycemic Disorders; Serum Lipid Disorders; Nutrition Disorders and Management; Parathyroid and Bone Mineral Disorders; Disorders of the Pituitary Gland; Reproductive Endocrinology Disorders; and Disorders of the Thyroid Gland. The panel of experts identified the cognitive knowledge base and associated clinical skills for theses areas needed by endocrinologists to provide competent and optimal care for patients with endocrine disorders. The areas were expanded to include an 11th section on Pediatric Endocrinology in 2008.

The ASAP provides a core curriculum with updated information on the evaluation, diagnosis, treatment, and management of endocrine disease. This curriculum has been updated every three years to keep endocrinologists at the cutting edge of the subspecialty. The ASAP fulfills the cognitive needs of the endocrinologist to be effective and competent in delivering optimal endocrine care. ASAP also provides an opportunity for endocrinologists to meet, in part, state licensure requirements for CME. Moreover, the program assists endocrinologists in preparation and maintenance of their subspecialty certification.

Learning Objectives

Through this educational activity, participants will be able to:

  • Understand the pathophysiology of endocrine diseases.
  • Recognize the relationship between pathophysiology and approach to evaluation, diagnosis, and management.
  • Review and assess updated information regarding recognition and management of endocrine diseases.
  • Review and assess the current and new therapeutic options for endocrine diseases.
  • Improve current management and care of patients with endocrine diseases.

Target Audience

Clinical Endocrinologists and Endocrine Fellows-in-Training

Learner Bill of Rights

The American Association of Clinical Endocrinologists (AACE) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill or performance. As part of AACE’s duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:

CONTENT that:

  • Promotes improvements or quality in healthcare;
  • Is valid, reliable and accurate;
  • Offers balanced presentations that are free of commercial bias for or against a product/service;
  • Is vetted through a process that resolves any conflicts of interests of planners, teachers or authors;
  • Is driven and based on learning needs, not commercial interests;
  • Addresses the stated objectives or purpose; and
  • Is evaluated for its effectiveness in meeting the identified educational need.

A LEARNING ENVIRONMENT that:

  • Supports learners’ ability to meet their individual needs;
  • Respects and attends to any special needs of the learners;
  • Respects the diversity of groups of learners; and
  • Is free of promotional, commercial and/or sales activities.

DISCLOSURE of:

  • Relevant financial relationships planners, teachers and authors have with commercial interests related to the content of the activity; and
  • Commercial support (funding or in-kind resources) of the activity.

Accreditation Statement

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of 76.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Declaration of Disclosure and Conflicts of Interest

It is the policy of AACE to ensure balance, independence, objectivity and scientific rigor in all of its CME activities. Presentation content may include discussion of an unlabeled use of a commercial product or an investigational use of a product not yet approved for any purpose. AACE requires that participating faculty disclose to the audience any product(s) and its use(s) discussed in the educational activity that are unapproved/unlabeled for the use by the FDA or still considered investigational in nature.

Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships. "Relevant financial relationships" are financial relationships in any amount occurring within the past 12 months that create a conflict of interest. AACE requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educational activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by AACE for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations.

The intent of this disclosure is not to prevent a speaker with commercial affiliations from presenting, but rather to provide learners with information from which they may make their own judgments. Informed learners are the final safeguards in assuring that a CME activity is independent from commercial influence.

CME Accreditation Committee Disclosures

Dr. Felice Caldarella reports that he has received speaker honoraria from Eli Lilly and Company and fees from Novo Nordisk A/S for research. Dr. Caldarella has no identified conflicts of interest.

Dr. Leslie J. De Groot reports that he does not have any relevant financial relationships with any commercial interests. Dr. De Groot has no identified conflicts of interest.

Dr. Maria Fleseriu reports that she has received speaker/consultant honoraria from Ipsen and Novartis AG and Advisory Board honoraria from Endo Pharmaceuticals. Dr. Fleseriu has no identified conflicts of interest.

Dr. Michael S. Irwig reports that he has received speaker honoraria from Bayer Schering Pharma AG. Dr. Irwig has no identified conflicts of interest.

Dr. Stanley S. Schwartz reports that he has received speaker/Advisory Board honoraria from Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, and Takeda Pharmaceutical Company Limited, speaker honoraria from Bristol-Myers Squibb/AstraZeneca, Merck & Co., Inc., and Santarus, Inc., and Advisory Board honoraria from Medtronic, Inc. Dr. Schwartz has no identified conflicts of interest.

Dr. Dace L. Trence reports that she has received research grant support for her role as Principal Investigator from Novo Nordisk A/S and Halozyme Therapeutics; and is a stockholder of Medtronic, Inc. and sanofi-aventis U.S. LLC. Dr. Trence has no identified conflicts of interest.

Dr. Bruce Trippe reports that he has received speaker honoraria from AstraZeneca, Eli Lilly and Company, GlaxoSmithKline plc, Novo Nordisk A/S and Tethys Bioscience. Dr. Trippe has no identified conflicts of interest.

Dr. Surendra K. Varma reports that he does not have any relevant financial relationships with any commercial interests. Dr. Varma has no identified conflicts of interest.

Dr. Pasquale Palumbo reports that he does not have any relevant financial relationships with any commercial interests. Dr. Palumbo has no identified conflicts of interest.

*Dr. Intekhad Ahmed reports that he has received speaker honoraria from Eli Lilly and Company, sanofi-aventis U.S. LLC, and Takeda Pharmaceutical Company Limited. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Ahmed has no identified conflicts of interest.

Dr. Susan Braithwaite reports that she does not have any relevant financial relationships with any commercial interests. Dr. Braithwaite has no identified conflicts of interest.

*Dr. Maria Regina Castro reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Castro has no identified conflicts of interest.

*Dr. Bart Clarke reports that he has received research grant support for his role as Principal Investigator from NPS Pharmaceuticals and honoraria from Amgen Inc. for his role as Data Monitoring Committee Member. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Clarke has no identified conflicts of interest.

*Dr. Amir Hamrahian reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Hamrahian has no identified conflicts of interest.

*Dr. Romesh Khardori reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Khardori has no identified conflicts of interest.

*Dr. Jeffrey Mechanick reports that he has received speaker honoraria from Abbott Laboratories and Consensus Medical Communications and conference attendance fees from sanofi-aventis U.S. LLC. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Mechanick has no identified conflicts of interest.

*Dr. Donald Smith reports that he has received speaker honoraria from Abbott Laboratories, AstraZeneca, Daiichi Sankyo Company, Limited, and Merck & Co., Inc./Schering Plough. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Smith has no identified conflicts of interest.

Dr. Phyllis Speiser reports that she does not have any relevant financial relationships with any commercial interests. Dr. Speiser has no identified conflicts of interest.

*Dr. Joseph Torre reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Torre has no identified conflicts of interest.

*Dr. Batul Valika reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Valika has no identified conflicts of interest.

*Dr. Adrian Vella reports that he has received research grant support from Merck & Co., Inc. and Daiichi Sankyo Company, Limited for his role as Principal Investigator, and consultant honoraria from F. Hoffman-La Roche Ltd and sanofi-aventis U.S. LLC. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Vella has no identified conflicts of interest.

* denotes individual is both a Section Editor and an author

Dr. Robert J. Anderson reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will include discussion of use of spironolactone in hirsutism. Dr. Anderson has no identified conflicts of interest.

Dr. David C. Aron reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Aron has no identified conflicts of interest.

Dr. Salomon Banarer reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will include discussion of the use of octreotide for sulfonylurea and netaglinide induced hypoglycemia. Dr. Banarer has no identified conflicts of interest.

Dr. Harold Bays reports that he has received clinical trial research grant support and Advisory Panel honoraria from Arena Pharmaceuticals, Inc. and VIVUS Inc., and clinical trial research grant support from Orexigen. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Bays has no identified conflicts of interest.

Dr. Beverly M. K. Biller reports she has received research grant support (to her hospital) for her role as Primary Investigator from Eli Lilly and Company, and consultant honoraria and research grant support (to her hospital) for her role as Principal Investigator from Novo Nordisk A/S and Pfizer Inc. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Biller has no identified conflicts of interest.

Dr. Zachary T. Bloomgarden reports that he has received speaker/Advisory Panel/consultant honoraria from Merck & Co., Inc., consultant honoraria and stock from Novartis AG, speaker honoraria from GlaxoSmithKline plc and Novo Nordisk A/S, Advisory Panel honoraria from AstraZeneca, Bristol-Myers Squibb, Biodel Inc., and Boehringer Ingelheim GmbH, consultant honoraria from Dainippon Sumimoto Pharma Co, Ltd. and Forest Laboratories, Inc., and stock from C.R. Bard, Inc., Covidien, F. Hoffman-La Roche Ltd., and Stryker. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Bloomgarden has no identified conflicts of interest.

Dr. James T. Bonucchi reports that he has received speaker honoraria from Abbott Laboratories and sanofi-aventis U.S. LLC. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Bonucchi has no identified conflicts of interest.

Dr. Matthew Brady reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Brady has no identified conflicts of interest.

Dr. Emmanuel L. Bravo reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Bravo has no identified conflicts of interest.

Dr. Elise M. Brett reports that her spouse has received an employee salary from Novo Nordisk A/S. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Brett has no identified conflicts of interest.

Dr. Karen C. Burns reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Burns has no identified conflicts of interest.

Dr. Pauline M. Camacho reports that she has received research grant support for her role as Primary Investigator from Eli Lilly and Company and Procter & Gamble. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Camacho has no identified conflicts of interest.

Dr. Carolina M. Casellinireports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Casellini has no identified conflicts of interest.

Dr. Anil Chandel reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Chandel has no identified conflicts of interest.

Dr. Ming Chen reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Chen has no identified conflicts of interest.

Dr. Vicky Cheng reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cheng has no identified conflicts of interest.

Dr. Sunita Cheruvu reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cheruvu has no identified conflicts of interest.

Dr. Rhoda Cobin reports that she has received speaker honoraria from Abbott Laboratories, AstraZeneca, and Bristol-Myers Squibb. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cobin has no identified conflicts of interest.

Dr. Ronald N. Cohenreports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cohen has no identified conflicts of interest.

Dr. Maria L. Collazo-Clavell reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Collazo-Clavell has no identified conflicts of interest.

Dr. David M. Cook reports that he has received speaker honoraria and research grant support from Eli Lilly and Company, speaker honoraria from Pfizer Inc, and research grant support from Endo Pharmaceuticals. He reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cook has no identified conflicts of interest.

Dr. Glenn R. Cunningham reports that he has received consultant fees and Advisory Panel honoraria from Endo Pharmaceuticals, grant support from F. Hoffman-La Roche Ltd for his role as Site Principal Investigator, Advisory Panel consulting fees from GlaxoSmithKline plc, speaker honoraria from Merck & Co., Inc., and speaker honoraria and grant support for his role as Site Principal Investigator from Solvay Pharmaceuticals/Abbott Laboratories. He reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Cunningham has no identified conflicts of interest.

Dr. Andjela Drincic reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Drincic has no identified conflicts of interest.

Dr. Michael P. Dube reports that he has received research support for his role as Investigator from Gilead, Merck & Co., Inc., and Tibotec Pharmaceuticals. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Dube has no identified conflicts of interest.

Dr. Jose A. Espinosa reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Espinosa has no identified conflicts of interest.

Dr. Shereen Ezzat reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Ezzat has no identified conflicts of interest.

Dr. Carmel M. Fratianni reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Fratianni has no identified conflicts of interest.

Dr. Walter Futterweit reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Futterweit has no identified conflicts of interest.

Dr. Michael Garcia reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Garcia has no identified conflicts of interest.

Dr. Thomas W. Gardner reports that he has received consultant honoraria from clarus therapeutics inc. and GSK. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Gardner has no identified conflicts of interest.

Dr. Isabelle M. Germano reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Germano has no identified conflicts of interest.

Dr. Suzan Gharaibeh reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Gharaibeh has no identified conflicts of interest.

Dr. J. Michael Gonzalez-Campoy reports that he has received speaker honoraria from Altru Health System, the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, American Association of Occupational Health Nurses, Association of American Indian Physicians, Blue Cross-Blue Shield Minnesota, Children’s Hospital—Minneapolis, Christ Medical Center—Chicago, Council of State Bioscience Assoc (CSBA), Eastern European Medical Society, Eau Claire Sacred Heart Hospital, Forest Laboratories, Inc., GlaxoSmithKline plc, Health East Hospital, HealthPartners, Hennepin County Medical Center, International Society of Clinical Densitometrists, Iowa Medical Society, La Crosse-Franciscan Skemp, Mercy Health System, Minnesota Academy of Family Physicians, Minnesota Academy of Medicine, Minnesota Academy of Physician Assistants, Minnesota Midwest Chapter of AACE, Minnesota Psychiatric Society, Northwestern Medical Conference, Preventive Cardiovascular Nurses Association, Ramsey Medical Society, Regions Hospital, Santarus, Inc., Sioux Valley Hospital, SouthEast Lipid Association, St. James Hospital, St. Marys-Duluth Clinic, St. Paul Heart Clinic, Star of the North Conference, United Hospital, Univ of Minnesota—Duluth, Univ. of Minnesota—Minneapolis, University of Texas Medical Branch, University of Wisconsin-Superior; speaker/consultant honoraria from Consensus Medical Communications and Merck & Co., Inc.; speaker/consultant honoraria and research grant support from Boehringer Ingelheim GmbH and Pfizer Inc.; consultant honoraria and research grant support from Leptos, Medtronic, Inc., and National Institutes of Health (NIH); research grant support from Amylin Pharmaceuticals, Inc., AstraZeneca, Ipsen, MNCOME Foundation, Novartis AG, NovoNordisk A/S, sanofi-aventis U.S. LLC, Takeda Pharmaceuticals, Inc.; consultant honoraria from Allergan, Inc., the American Medical Association, the Center for Disease Control, EndocrineWeb, Kitch Attorneys & Counselors, National Diabetes Education Program Steering Committee, National Minority Quality Forum, F. Hoffman-La Roche Ltd, Shindler-Neff Law Firm, and WebMD/Medscape; and a fee from the University of Minnesota, DSS Trial for his role as Data and Safety Monitoring Board member. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Gonzalez-Campoy has no identified conflicts of interest.

Dr. Neil F. Goodman reports that he has received speaker honoraria from Bayer AG. He reports that his manuscript will include discussion of the use of metformin in polycystic ovary syndrome and the use of testosterone in hypoactive sexual desire disorder in women. Dr. Goodman has no identified conflicts of interest.

Dr. Ketan G. Goswami reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Goswami has no identified conflicts of interest.

Dr. Sheryl Green reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Green has no identified conflicts of interest.

Dr. Smita Gupta reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Gupta has no identified conflicts of interest.

Dr. Mouhammad Amir Habra reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Habra has no identified conflicts of interest.

Dr. Michael J. Haller reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Haller has no identified conflicts of interest.

Dr. Osama Hamdy reports that he has received speaker honoraria from Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Novo Nordisk A/S, Merck & Co., Inc., and Takeda Pharmaceutical Company Limited. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Hamdy has no identified conflicts of interest.

Dr. Michael J. Heard reports that he has received a salary from CATOBGYN, LLC for his role as Partner/Medical Director, a speaker salary from OB/GYN Board Prep, LLC, speaker honoraria from Warner Chilcott, and speaker/consultant honoraria from Sigma-Tau Pharmaceuticals, Inc. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Heard has no identified conflicts of interest.

Dr. Michael J. Hogan reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Hogan has no identified conflicts of interest.

Dr. Caroline B. Huang reports that she has received speaker honoraria from Eli Lilly and Company and sanofi-aventis U.S. LLC. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Huang has no identified conflicts of interest.

Dr. Daniel L. Hurley reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Hurley has no identified conflicts of interest.

Dr. Adriana Ioachimescu reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Ioachimescu has no identified conflicts of interest.

Dr. Robert E. Izquierdo reports that he has received research grant support from Diamyd Medical AB and MacroGenics, Inc. He also reports that his manuscript will include discussion of the use of levothyroxine for Euthyroid sick syndrome. Dr. Izquierdo has no identified conflicts of interest.

Dr. Paul S. Jellinger reports that he has received speaker honoraria from Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, and Takeda Pharmaceutical Company Limited. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Jellinger has no identified conflicts of interest.

Dr. Lois G. Jovanovic reports that she has received clinical trial grant support from DexCom, Inc., Eli Lilly and Company, JDRF, GluMetrics, Inc., MannKind Corporation, Medtronic MiniMed, Inc., National Institutes of Health (NIH), Novo Nordisk A/S, and Pfizer Inc. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Jovanovic has no identified conflicts of interest.

Dr. Ann E. Kearns reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Kearns has no identified conflicts of interest.

Dr. Abbas E. Kitabchi reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Kitabchi has no identified conflicts of interest.

Dr. Michael Kleerekoper reports that he has received speaker honoraria from Amgen Inc. and Eli Lilly and Company. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Kleerekoper has no identified conflicts of interest.

Dr. Bethany J. Klopfenstein reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Klopfenstein has no identified conflicts of interest.

Dr. Seema Kumar reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Kumar has no identified conflicts of interest.

Dr. Stephanie Lee reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Lee has no identified conflicts of interest.

Dr. Dan Lender reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Lender has no identified conflicts of interest.

Dr. Melissa Li-Ng reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Li-Ng has no identified conflicts of interest.

Dr. Michelle F. Magee reports that she received research grant support and speaker/Advisory Board honoraria from sanofi-aventis U.S. LLC, education program grant support and speaker honoraria from Novo Nordisk A/S, and research study grant support for Takeda Pharmaceutical Company Limited. She reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Magee has no identified conflicts of interest.

Dr. Antoine Makdissi reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Makdissi has no identified conflicts of interest.

Dr. Ian Marshall reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will include discussion of aromatase inhibitors to limit the conversion of androgens to estrogens. Dr. Marshall has no identified conflicts of interest.

Dr. Anthony L. McCall reports that he has received lecture honoraria from Amylin Pharmaceuticals, Inc./Eli Lilly and Company and Merck & Co., Inc., contract research clinical trial funding support from sanofi-aventis U.S. LLC, and consulting fees from Pfizer Inc. for evaluation of visiting professors. He reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. McCall has no identified conflicts of interest.

Dr. Karen McCowen reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. McCowen has no identified conflicts of interest.

Dr. Bryan McIver reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. McIver has no identified conflicts of interest.

Dr. Adi E. Mehta reports that he has received Speaker’s Bureau honoraria from Amylin Pharmaceuticals, Inc./Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk A/S, and Pfizer Inc. He reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Mehta has no identified conflicts of interest.

Dr. Ram K. Menon reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Menon has no identified conflicts of interest.

Dr. Terri Montague reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Montague has no identified conflicts of interest.

Dr. Sunder Raj D. Mudaliar reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Mudaliar has no identified conflicts of interest.

Dr. Barbara T. Murphy reports that she has received Scientific Advisor honoraria from Genzyme Corporation. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Murphy has no identified conflicts of interest.

Dr. Nicole S. Nader reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Nader has no identified conflicts of interest.

Dr. Timothy O’Brienreports that he has received grant support for his role as meeting organizer from Boehringer Ingelheim GmbH, Novo Nordisk A/S, Pfizer Inc., and sanofi-aventis U.S. LLC, Scientific Advisory Board honoraria and grant support for his role as meeting organizer from Merck & Co., Inc., Scientific Advisory Board honoraria from the Menarini Group, and research grant support from Medtronic Minimed, Inc. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. O’Brien has no identified conflicts of interest.

Dr. Arti Patel reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Patel has no identified conflicts of interest.

Dr. Anson Pham reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Pham has no identified conflicts of interest.

Dr. Kalmon D. Post reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Post has no identified conflicts of interest.

Dr. Helena W. Rodbard reports that she has received speaker honoraria from Bristol-Myers Squibb and Merck & Co., Inc.; Advisory Board honoraria from GlaxoSmithKline plc. and Mannkind Corporation; clinical research fees from sanofi-aventis U.S. LLC.; speaker/Advisory Board honoraria from AstraZeneca; clinical research/Advisory Board fees from Biodel, Inc.; speaker honoraria and clinical research fees from Novo Nordisk A/S; and reports that her spouse has received consultant fees from DexCom, Inc. and sanofi-aventis U.S. LLC. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rodbard has no identified conflicts of interest.

Dr. Luis J. Rodriguez-Rigau reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rodriguez-Rigau has no identified conflicts of interest.

Dr. Henry Rohrs reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rohrs has no identified conflicts of interest.

Dr. Susan R. Rose reports that she has received research support for her role as Investigator from Pfizer Inc. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rose has no identified conflicts of interest.

Dr. Arlan L. Rosenbloom reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rosenbloom has no identified conflicts of interest.

Dr. Kristina I. Rother reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will include discussion of the use of exenatide in the regeneration of beta cells, and the use of anti-CD3 antibodies (teplizumab and otelixizumab) and anti-CD20 antibodies (rituximab) in the preservation of beta cells. Dr. Rother has no identified conflicts of interest.

Dr. Karen R. Rubin reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Rubin has no identified conflicts of interest.

Dr. W. Frederick Schwenk reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Schwenk has no identified conflicts of interest.

Dr. F. John Service reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Service has no identified conflicts of interest.

Dr. Pankaj Shah reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Shah has no identified conflicts of interest.

Dr. Janet H. Silverstein reports that she has received consultant honoraria from Genentech, Inc., Novo Nordisk A/S, and Serono. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Silverstein has no identified conflicts of interest.

Dr. Ravi S. J. Singh reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will include discussion of use of ranibizumab and bevacizumab for diabetic retinopathy. Dr. Singh has no identified conflicts of interest.

Dr. Mario Skugor reports that he has received speaker honoraria from Merck & Co., Inc., Novo Nordisk A/S, and Novartis AG. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Skugor has no identified conflicts of interest.

Dr. Keith D. Smith reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Smith has no identified conflicts of interest.

Dr. Marius Stan reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Stan has no identified conflicts of interest.

Dr. Elizabeth A. Stephens reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Stephens has no identified conflicts of interest.

Dr. Kristin Tarbell reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will include discussion of the use of teplizumab and otelixizumab, rituximab, and diamyd in the treatment of new-onset type 1 diabetes. Dr. Tarbell has no identified conflicts of interest.

Dr. Asha Thomas reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Thomas has no identified conflicts of interest.

Dr. Inas Thomas reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Thomas has no identified conflicts of interest.

Dr. Angelina L. Trujillo reports that she has received an employee salary from Boehringer Ingelheim GmbH. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Trujillo has no identified conflicts of interest.

Dr. Randall J. Urban reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Urban has no identified conflicts of interest.

Dr. Joseph G. Verbalis reports that he has received consultant honoraria from Astellas Pharma US, Inc., Cardiokine, OTSUKA PHARMACEUTICAL CO., LTD. and sanofi-aventis U.S. LLC. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Verbalis has no identified conflicts of interest.

Dr. Michael A. Via reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Service has no identified conflicts of interest.

Dr. Aaron I. Vinik reports that he has received speaker honoraria from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline plc, and Pfizer Inc., consultant honoraria from KV Pharmaceutical Company, R.W. Johnson Pharmaceutical Research Institute, and Tercica, Inc., and speaker/consultant honoraria from The Ansar Group, Inc., AstraZeneca, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, sanofi-aventis U.S. LLC, and Takeda Pharmaceutical Company Limited. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Vinik has no identified conflicts of interest.

Dr. Daniel Weiss reports that he received speaker honoraria from AstraZeneca, Bristol-Myers Squibb, Daiichi Sankyo Company, Limited, Eli Lilly and Company, and GlaxoSmithKline plc, research fund support for his role as Clinical Trial Principal Investigator from Boehringer Ingelheim GmbH, Cardiokine, Isis Pharmaceuticals, Inc., MannKind Corporation, NovoNordisk A/S, F. Hoffman-La Roche Ltd, and Tolerx, Inc., and speaker honoraria and research fund support for his role as Clinical Trial Principal Investigator from Amylin Pharmaceuticals, Inc., sanofi-aventis U.S. LLC, and Takeda Pharmaceutical Company Limited. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Weiss has no identified conflicts of interest.

Dr. Robert A. Wermersreports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Wermers has no identified conflicts of interest.

Dr. Sydney A. Westphal reports that she does not have any relevant financial relationships with any commercial interests. She also reports that her manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Westphal has no identified conflicts of interest.

Dr. Dwain E. Woode reports that he does not have any relevant financial relationships with any commercial interests. He also reports that his manuscript will not include discussion of any investigational or unlabeled use(s) of a product. Dr. Woode has no identified conflicts of interest

Ms. Katherine V. Mann reports that she does not have any relevant financial relationships with any commercial interests. Ms. Mann has no identified conflicts of interest.

To qualify for the AACE Member rate of $225, you will need to verify your AACE membership information by logging into this site. We have also added

  • AACE Member - Fellow-in-Training rate: $125.
  • AACE Member - Residents: $75.
  • AACE Member - Medical Students: $25.
  • AACE Member - Retired (Retired Domestic, Retired International, Senior Domestic, Emeritus Domestic, & Emeritus International):$150.00
To purchase ASAP at the AACE Member – Medical Student price of $25, please contact the AACE office at (904) 353-7878 or Contact CME

Please log in to aace.com for AACE Member pricing

If you are not an AACE Member, the non-member rate for ASAP is $325.


To sign up for ASAP, you need to:

  • Create a user name.
  • Complete the required contact and billing information.
  • Pay using your credit card.

Upon submission of credit card payment, you will receive an automated email receipt from AACE, confirming your credit card transaction. Please note that you will not have access to the ASAP sections at this point. Upon verification of funds, you will receive an activation email, including your American Association of Clinical Endocrinologists Self-Assessment Program USERNAME and PASSWORD. You will then have access to the ASAP sections. You will be required to change your password on initial login.


If you feel there is an error, AACE Members are reminded to log in to receive AACE Member pricing. All others, please contact AACE.

Click here to add this ASAP subscription to your cart.

Before you begin this educational activity, AACE requires that you read the entire CME Information.

The CME Information tab is located across the top of your screen. If you have not read this information, please do so now and return to this page by selecting the START ASAP SECTION tab.

To launch ASAP, please check here to attest that you have read and understood the CME required elements.

AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.